Financial statements Hipromine
Cash inflows of HIPROMINE
|
Year
|
2023
|
|---|---|
| Net cash from operating expenses | -28 017 350,80 |
| Net cash flow from investing activities | -130 788 552,15 |
| Net cash flow from financial activities | 168 621 909,28 |
| Total net cash flow | 9 816 006,33 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.